"Hope Center for Blood Disease and Cancer Care, providing cancer and blood disease care"

During the past decade, Hope Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hope Cancer Center" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "OSI Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Hope Cancer Center" are "Colorectal Cancer" (3 trials), "Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Hope Cancer Center" in a lesser frequency.

Most popular intervention types in "Hope Cancer Center" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (2 trials), "Leucovorin" (2 trials), "Oxaliplatin" (2 trials), "Anastrozole" (1 trials) and "Axitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hope Cancer Center" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hope Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hope Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hope Cancer Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".